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Abstract Ectopic lymphoid follicles are a key feature of
chronic inflammatory autoimmune and infectious diseases,
such as rheumatoid arthritis, Sjögren's syndrome, and
Helicobacter pylori-induced gastritis. Homeostatic chemo-
kines are considered to be involved in the formation of such
tertiary lymphoid tissue. High expression of CXCL13 and
its receptor, CXCR5, has been associated with the forma-
tion of ectopic lymphoid follicles in chronic infectious
diseases. Here, we defined the role of CXCR5 in the
development of mucosal tertiary lymphoid tissue and
gastric inflammation in a mouse model of chronic H. pylori
infection. CXCR5-deficient mice failed to develop orga-
nized gastric lymphoid follicles despite similar bacterial
colonization density as infected wild-type mice. CXCR5
deficiency altered Th17 responses but not Th1-type cellular
immune responses to H. pylori infection. Furthermore,
CXCR5-deficient mice exhibited lower H. pylori-specific
serum IgG and IgA levels and an overall decrease in
chronic gastric immune responses. In conclusion, the
development of mucosal tertiary ectopic follicles during
chronic H. pylori infection is strongly dependent on the
CXCL13/CXCR5 signaling axis, and lack of de novo
lymphoid tissue formation attenuates chronic immune
responses.
Keywords Chemokines.Tertiary lymphoid tissue.Chronic
gastritis.Helicobacter pylori
Introduction
Chronic inflammatory diseases caused by autoimmune or
pathogen-induced processes are often associated with the
neogenesis of tertiary lymphoid tissues in non-lymphoid
organs. These organized microstructures resemble conven-
tional secondary lymphoid organs, with high endothelial
venules, well-defined B and T cell zones, and specialized
populations of differentiated stromal cells. The principal
molecules mediating embryonic lymphoid organogenesis,
i.e., inflammatory cytokines of the tumor necrosis factor/
lymphotoxin (LT) family and homeostatic chemokines, are
also responsible for the complex sequence of events leading
to de novo lymphoid tissue neogenesis [1–3]. Chemokine
(C-X-C motif) ligand 13 (CXCL13) and its receptor
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DOI 10.1007/s00109-010-0658-6CXCR5 have been linked to B cell recruitment in
autoimmune diseases such as rheumatoid arthritis, multiple
sclerosis, and experimental autoimmune encephalomyelitis,
in humans and in animal disease models [4–8]. We recently
provided direct evidence for a role of the homeostatic
chemokines CXCL13, CCL19, and CCL21 in the formation
of tertiary lymphoid tissues in a murine model of chronic
antigen-induced arthritis [9]. Furthermore, ectopic trans-
genic expression of all three chemokines was sufficient to
induce de novo lymphoid neogenesis [10–13]. Indirect
evidence suggests that the same molecular mechanisms also
trigger the formation of tertiary lymphoid tissues during
chronic inflammation associated with infectious diseases,
i.e., Lyme arthritis [14], hepatitis C-induced liver inflam-
mation [15], Propriobacterium acnes [16], Mycobacterium
tuberculosis [17, 18], and Helicobacter pylori infection [19,
20].
Chronic inflammation due to persistent H. pylori
infection can give rise to organized tertiary lymphoid
tissues in the gastric mucosa, also called mucosa-
associated lymphoid tissue (MALT). MALT represents a
premalignant condition that can eventually lead to gastric
MALT lymphomagenesis in a small subset of chronically
infected individuals. CXCL13 and its receptor, CXCR5, are
highly expressed in reactive and/or malignant areas of
lymphoid organization that develop in H. pylori-infected
stomach mucosa of humans [20, 21]o ri nHelicobacter
infection models in mice [22]. It was suggested that the
CXCR5/CXCL13 signaling axis might be a key molecular
regulator of tertiary lymphoid organ formation during the
course of Helicobacter-induced gastritis. However, direct
experimental evidence has yet to confirm this hypothesis.
Therefore, we infected wild-type (Wt) and CXCR5-
deficient (CXCR5
−/−)m i c ew i t ht h eH. pylori strain
Hp76 to investigate whether the effector function of de
novo developed gastric lymphoid tissue contributes to the
sequence and level of chronic infectious inflammation.
CXCR5 deficiency leads to a complete lack of gastric
tertiary lymphoid tissue formation and an overall reduc-
tion of chronic gastric inflammation. Thus, our results
establish that H. pylori-induced formation of tertiary
lymphoid tissues is crucially dependent on CXCL13/
CXCR5-mediated signaling events.
Materials and methods
Mice
CXCR5 knockout mice [23] were backcrossed with
C57BL/6 mice for 12 generations. CXCR5
−/− and
C 5 7 B L / 6m i c ew e r er a i s e du n d er specific pathogen-free
conditions and used at 2–3 months of age. All animal
studies were performed according to institutional and state
guidelines.
H. pylori infection
The mouse-adapted Hp76 strain of H. pylori [24]i sa
spontaneous streptomycin-resistant derivative of P49. The
strain expresses VacA but is CagA negative [25] and was
grown under microaerophilic conditions in brain heart
infusion broth (Becton Dickinson) supplemented with
10% fetal calf serum (FCS), sodium bicarbonate 100 mM,
streptomycin 400 μg/ml, vancomycin 10 μg/ml, nystatin
10 μg/ml, and trimethoprim 2.5 μg/ml. Mice were intra-
gastrically inoculated with 2.5×10
8 CFU H. pylori/100 μl
phosphate buffered solution (PBS) after being fasted for
18 h on three successive occasions within a 6-day period.
To confirm chronic infection with H. pylori, half of the
stomach was homogenized, and bacterial colonization was
determined by a plate-dilution method at indicated time
points after infection. The second half of the stomach was
processed for histological analysis. For the preparation of
H. pylori lysate, bacteria were harvested from agar plates,
suspended in PBS, sonicated for 90 s at 4°C, and then
centrifuged at 2,500×g. The supernatant was harvested, and
protein concentration was determined by Bradford assay.
Preparation of cell suspensions and proliferation assay
Spleen and mesenteric lymph node (mLN) cell suspensions
were obtained by disruption of the organ in PBS/2% FCS
followed by hypotonic lysis to deplete red blood cells. For
in vitro proliferation assays, 1×10
6 splenocytes or cells
from the mLN were cultured in 200 μl RPMI/10% FCS/
10 U/ml interleukin (IL)-2 in the presence or absence of
100 μg/ml H. pylori lysate in 96-well round-bottom
microtiter plates (in octuplicates) at 37°C for 72 h. T cell
proliferation was assessed by measuring the amounts of
interferon-γ (IFN-γ), IL-17, and IL-22 in culture super-
natants by enzyme-linked immunosorbent assay (ELISA).
Enzyme-linked immunosorbent assay (ELISA)
For the assessment of H. pylori-specific serum antibody
levels, microtiter plates were coated with 10 μg/ml H.
pylori lysate, and bound antibodies were detected with
horseradish peroxidase (HRP)-conjugated antisera for IgG
or IgA (Southern Biotechnology) in conjunction with
3,3′,5,5′-tetramethylbenzidine (TMB) substrate. Sera were
diluted 1:500 for IgA and 1:400 for IgG measurements,
and the absorbance at 450 nm represents the relative anti-
H. pylori IgG or IgA value. All measurements were
performed in duplicates, and the Ig levels from different
mice were averaged.
1170 J Mol Med (2010) 88:1169–1180To quantitate serum cytokine levels or cytokine
expression in culture supernatants, microtiter plates were
coated with rat anti-mouse IFN-γ,r a ta n t i - m o u s eI L - 1 7 ,
or rat anti-mouse IL-22 (all Biolegend). Bound cytokines
were detected with biotinylated rat anti-mouse IFN-γ
(Becton Dickinson), biotinylated rat anti-mouse IL-17, or
biotinylated rat anti-mouse IL-22 (both Biolegend),
followed by HRP-conjugated streptavidin and TMB
substrate. Recombinant mouse IFN-γ (Becton Dickinson),
IL-17, and IL-22 (Biolegend) served as standards. Serum
was prepared from blood obtained by cardiac puncture and
stored at −80°C.
Histological evaluation and immunohistology
The following primary antibodies were used: Alexa 488-
labeled rat anti-mouse CD3 (Biolegend), purified rat ani-
mouse CD138, and biotinylated rat anti-mouse B220
(Becton Dickinson), polyclonal rabbit anti-mouse CD3
and CD31 (Abcam), biotinylated rat anti-mouse F4/80
(Serotec), rat anti-mouse PNAd and rat anti-mouse
follicular dendritic cell (FDC)-M1 (Becton Dickinson),
rat anti-mouse Ki67 (Dako), biotinylated rat anti-mouse
Foxp3 and Pacific Blue-labeled hamster anti-mouse
CD11c (eBiosciences), and polyclonal rabbit anti-H.
pylori (Dako). For paraffin sections, tissues were fixed in
4% phosphate-buffered formaldehyde, embedded in
paraffin, cut into 5-μm cross-sections, deparaffinized,
and demasked by heat (citrate buffer, pH 6.0) or
trypsinization (F4/80, PNAd). For cryosections, tissues
were frozen in Tissue Tek OCT compound (Sakura
Finetek), cut longitudinal into 5- to 8-μm sections, fixed
for 10 min in −20°C acetone, and rehydrated in 50 mM
Tris-buffered saline, pH 7.6. Endogenous peroxidase
activity was blocked with 3% H2O2, and a biotin-
blocking step (Vector Laboratories) was performed before
biotinylated antibodies were applied. Primary antibodies
were incubated for 2 h at room temperature, followed by
an appropriate secondary antibody or/and a streptavidin
conjugate (alkaline phosphatase or HRP). Alkaline phos-
phatase activity was detected using Fast blue salt (Sigma-
Aldrich). HRP activity was detected using the AEC
detection system (Dako). All slides were mounted in
Mowiol solution (11.7% w/v Mowiol, 29.4% w/v
glycerine, 0.12 M Tris, pH 8.5). Images were acquired
with a Zeiss Axiophot fluorescence microscope with an
Axiocam HRc camera and further processed using
AxioVision 4.5 software (Carl Zeiss).
The intraepithelial lymphocytes were quantified in H&E
stained sectionsbycountingthe small and round lymphocytes
within the basal portion of the surface epithelium and the
gastric pits per 100 epithelial cells according to a previously
published standard method used in routine pathology [26].
Statistical analysis
Results are expressed as arithmetic means ± standard
error of the mean (SEM). Values of P<0.05 were
considered statistically significant and determined either
by an unpaired, two-tailed Mann–W h i t n e yo ra nu n p a i r e d ,
two-tailed Student's t test, as indicated.
Results
H. pylori infectious status and inflammation
To assess the role of CXCR5 in the development of H.
pylori-induced gastric inflammation and lymphoid tissue
neogenesis, Wt and CXCR5
−/− mice were infected and
monitored with respect to bacterial colonization and gastric
inflammation (Fig. 1a–c). Colonization levels and pattern
were comparable in Wt and CXCR5
−/− mice 5 to 7 months
after inoculation with the mouse-adapted H. pylori strain
Hp76 (Fig. 1b). In both groups, bacteria were found
adherent to the surface of foveolar cells or between
epithelial cells of the gastric mucosa (Fig. 1c). H. pylori
was not detected in stomachs of uninfected animals (data
not shown).
Histomorphological and immunohistochemical analysis
was used to determine presence and phenotype of inflam-
matory infiltrates located in the submucosal and mucosal
gastric tissue. Gastritis was graded according to the updated
Sydney System [27]. The scoring system distinguishes
between active neutrophil-dominated and chronic inflam-
mation, characterized by the prevalence of macrophages,
lymphocytes, and plasma cells. All inflammatory infiltrates
were scored from 0 to 3. Wt mice exhibited a strong active
and a moderate chronic inflammation 7 months after
infection. In contrast, CXCR5
−/− mice showed significantly
reduced active inflammatory scores and only a minor
reduction of the chronic inflammatory score (Table 1).
We observed the formation of one or multiple highly
organized tertiary lymphoid tissues in chronically
infected Wt mice (Fig. 2a and Table 1). Remarkably, the
formation of ectopic lymphoid tissue was strongly
abrogated in CXCR5
−/− mice (Fig. 2b and Table 1). In
o n l yt w oo u to f1 3C X C R 5
−/− mice, loose lymphoid
aggregates were visible (Fig. 2b). The majority of CXCR5
−/−
mice displayed less Ki67 staining, a marker for epithelial
proliferation, in comparison to Wt mice, which showed
pronounced Helicobacter-induced epithelial proliferation
(Fig. 3a). Increase of intraepithelial lymphocytes (>25 IELs/
100 epithelial cells) and reactive epithelial changes including
epithelial regeneration and/or hyperplasia were also scored.
Both parameters were reduced in CXCR5
−/− mice compared
to Wt animals (Table 1 and Fig. 3b). Taken together,
J Mol Med (2010) 88:1169–1180 1171CXCR5
−/− mice developed less active and chronic gastric
inflammation than Wt controls (Table 1 and Fig. 3b).
Chronic infection with H. pylori causes the development of
highly organized ectopic lymphoid structures in Wt but not
in CXCR5
−/− mice
In Wt mice, tertiary lymphoid tissues developed fully within
5–7 months (Table 1) and displayed highly organized
microstructures up to 17 months after infection (Figs. 4a
and 5a–f; Table 1). This was strongly abrogated in H. pylori-
infected CXCR5
−/− mice (Fig. 4b and Table 1). Eleven out
of 13 CXCR5
−/− mice analyzed showed no tertiary lymphoid
tissue development (Table 1). In two cases (CXCR5
−/− No. 7
and No. 10, Table 1), an active chronic Helicobacter-induced
inflammation was accompanied by loose cellular aggregates
located in the submucosal and in the mucosal tissue.
However, the cellular aggregates consisted mainly of macro-
phages and some scattered lymphocytes with an abundance
of CD31
+ blood vessels adjacent to these structures. No
proper segregation into T and B cell zones and subsequently
no formation of germinal centers (GCs) were observed in
CXCR5
−/− mice (Fig. 4b).
Ectopic follicular structures, which developed regu-
larly in infected Wt mice (Table 1), displayed discrete T
cell and B cell areas characteristic of the compartmen-
talization exhibited by conventional lymphoid organs. In
addition to macrophages scattered throughout the sub-
mucosal and mucosal tissue, small clusters of macro-
phages adjacent to follicular structures were observed.
Within and adjacent to these lymphoid aggregates, an
abundance of CD31
+ blood vessels was detected
(Fig. 4a). Detailed analysis of these highly structured
lymphoid follicles revealed additional similarities to
conventional LNs, i.e., a number of blood vessels
expressed peripheral lymph node addressin (PNAd) and
therefore were characterized as high endothelial venules
(HEVs; Fig. 5a). These specialized HEVs allow
lymphocyte extravasation from the blood and represent
a specific feature of functional lymphoid organs. CD3
+ T
cell zones contained CD4
+,C D 8
+ (data not shown)
intermingled with CD11c
+ DCs, and regulatory Foxp3
+
T cells (Fig. 5b, c). Proliferating Ki-67
+ cells were
detected within the B cell-rich area (Fig. 5d) ,a n di ns o m e
organized tertiary lymphoid tissues, GC-like structures
were additionally defined by staining for CD138
+ plasma
Fig. 1 Comparable Helico-
bacter pylori gastric coloniza-
tion in Wt and CXCR5
−/− mice.
a Schematic representation of
the experimental H. pylori in-
fection model. b The degree of
H. pylori colonization in the
gastric mucosa of Wt (black
squares; n=7) and CXCR5
−/−
(open circles; n=10) mice was
assessed by colony counting 5
and 7 months after infection.
The degree of colonization was
comparable 5 and 7 months after
infection. Statistical significance
was calculated by unpaired
Mann–Whitney test. NS nonsig-
nificant. c H. pylori specimen
were also detected by immuno-
histochemical staining with an
anti-H. pylori antiserum and
hematoxylin counterstaining
7 months after infection (in red;
examples indicated by arrows).
A lower (upper panels) and
higher magnification (lower
panels) of each group is shown;
scale bars, 100 μm
1172 J Mol Med (2010) 88:1169–1180cells and/or FDCs (FDCs; Fig. 5e, f). Taken together,
chronic H. pylori infection triggered the formation of
organized tertiary lymphoid tissues with characteristics of
conventional secondary lymphoid organs. Most impor-
tantly, the development of tertiary lymphoid tissue was
strongly suppressed in CXCR5
−/− mice.
T cell-mediated immune responses to H. pylori are partially
impaired in H. pylori-infected CXCR5
−/− mice
The development of a Th1-predominant immune response
with production of IFN-γ has been observed in humans and
mice following infection with Helicobacter [28–30]. In
addition, the Th17 cytokine IL-17A has been reported to
play an important role in mucosal immune responses to
Helicobacter infection [31, 32]. Here, we tested if enhanced
IFN-γ, IL-17A, and IL-22 production was detectable in
response to chronic infection with H. pylori and if the
production of inflammatory mediators is altered by CXCR5
deficiency. Serum IFN-γ levels of chronically infected mice
were below the detection limit of our ELISA. Serum levels
of IL-17A were generally elevated after Helicobacter
infection, but this increase was not significantly altered in
CXCR5
−/− compared to Wt mice (data not shown). Next,
we used single-cell suspensions from spleens and mLNs of
infected mice and restimulated them with H. pylori antigen
in vitro. Splenocytes and mLN-derived lymphocytes from
Wt and CXCR5
−/− mice were equally capable of producing
IFN-γ in response to H. pylori sonicate 7 months after
infection (Fig. 6a). This suggests that both mouse strains
are capable of mounting a Th1-type cellular response to H.
pylori infection. In addition, splenocytes and mLN-derived
cells from infected Wt mice also produced increased IL-
17A levels compared to non-infected Wt mice. IL-17A
concentrations produced in splenocytes derived from
infected CXCR5
−/− mice were comparable to Wt cells,
whereas IL-17A production in mLN-derived cells from
infected CXCR5
−/− mice was significantly decreased in
response to H. pylori sonicate compared to Wt cells
(Fig. 6b). We also found that CXCR5 deficiency altered
Helicobacter-induced production of IL-22, another Th17-
derived cytokine, in mLN-derived cells (Fig. 6c, left panel).
Gastrointestinal immune responses directed against muco-
sal pathogens are predominantly induced in the mucosal
associated lymphoid organs, i.e., Peyer's patches (PPs) and
mLNs [33]. Hence, Helicobacter-induced cytokine produc-
tion was generally more prominent in lymphocytes derived
from mesenteric LNs than from the spleen, except for IL-
22. Overall, CXCR5 expression seems to influence Th17-
but not Th1-type cellular immune responses to H. pylori
infection.
H. pylori-specific serum IgA and IgG levels are decreased
in CXCR5
−/− mice
Next, we examined whether CXCR5 deficiency influenced
the production of anti-H. pylori-specific antibodies. Serum
samples from Wt and CXCR5
−/− mice were taken 4 (data
not shown) and 7 months after H. pylori infection, and anti-
H. pylori IgG and IgA titers were determined by ELISA.
Table 1 Gastric histology of Helicobacter pylori-infected mice
Mouse Active
(0–3)
Chronic
(0–3)
No.
of
TLOs
Intraepithelial
lymphocytes
Reactive
epithelial
changes
(0–2)
a
Wt
10 1 2 − 1
20 1 0 − 1
31 1 2 − 2
42 2 3 − 2
52 2 3 − 2
62 2 3 + 2
72 2 5 –6
b +2
82 1 2 + 2
92 1 1 + 2
10 2 1 3 + 2
11 3 1 1 + 2
12 1 1 0 − 1
CXCR5
−/−
10 1 0 − 1
21 1 0 − 1
30 1 0 − 0
42 1 0 − 1
51 1 0 − 1
60 1 0 − 1
72 2 1
c +2
80 0 0 − 0
90 1 0 − 1
10 3 2 1
c +2
11 0 1 0 − 2
12 0 1 0 − 2
13 0 1 0 − 2
Significance * NS ** NS *
0=absent, 1=mild, 2=moderate, 3=marked
− normal lymphocytic infiltration, + enhanced lymphocytic infiltrates
(>25 IEL/100 epithelial cells), NS nonsignificant
*P<0.05 (indicates statistical significance); **P<0.01 (indicates
statistical significance)
a0, no changes; 1, epithelial regeneration or epithelial hyperplasia; 2,
epithelial regeneration+epithelial hyperplasia
bSLOs plus GC
cUnorganized lymphoid aggregate
J Mol Med (2010) 88:1169–1180 1173The majority of H. pylori-infected Wt mice mounted a
strong anti-H. pylori response in comparison to uninfected
controls (Fig. 7a, b). In contrast, Helicobacter-specific IgA
and IgG levels were strongly reduced in infected CXCR5
−/−
mice (Fig. 7a, b) compared to infected Wt mice. Basal
serum levels for the same subclasses of immunoglobulin
are known to be comparable in both groups [23, 34]. In
addition, comparable antigen-specific Ig levels of the
various subclasses are observed in DNP-KLH-immunized
CXCR5
−/− and Wt mice [23]. Thus, we conclude that
impaired generation of Helicobacter-specific antibodies is
not caused by a general inability of CXCR5
−/− mice to
mount antigen-specific Ig responses to T cell-dependent
antigens.
Discussion
In the present study, we provide direct evidence for a
pivotal role of CXCR5 in the formation of tertiary
lymphoid tissue during Helicobacter-induced chronic
gastritis.
A decade ago, it was demonstrated that the ligand for
CXCR5 and CXCL13 is highly expressed in gastric
lymphoid follicles and in MALT lymphomas of patients
with chronic gastritis induced by H. pylori infection [20].
Additional clinical studies have correlated CXCL13/CXCR5
expression with infection-dependent formation of gastric
MALT and MALT lymphomas [21, 35]. In experimental
mouse models, i.e., chronic experimental tuberculosis and
Helicobacter-induced chronic gastritis, formation of lym-
phoid structures was observed accompanied by expression of
the homeostatic chemokine CXCL13, but also CCL19 and
CCL21 [17, 18, 22, 36]. However, a genetic in vivo model
that would causally link the CXCL13/CXCR5 signaling axis
to the pathology of H. pylori infection has not yet been
described. Here, we employ CXCR5
−/− mice to study
CXCR5-dependent formation of tertiary lymphoid tissues
during chronic H. pylori infection. We show that the
CXCL13/CXCR5 signaling axis is crucial for the
development of tertiary lymphoid tissues during H.
pylori-induced gastric inflammation. Five to seven months
post-Helicobacter instillation, Wt mice developed a
chronic H. pylori i n f e c t i o na c c o m p a n i e db yt h ef o r m a t i o n
of highly organized and fully functional ectopic lymphoid
follicles. Strikingly, CXCR5
−/− mice failed to develop
organized ectopic lymphoid follicles. This impaired
tertiary lymphoid tissue formation may be associated with
changes in the severity and maintenance of chronic
inflammation.
The majority of infected Wt animals developed an active
chronic gastritis with increased intraepithelial lymphocyte
Fig. 2 Helicobacter pylori-induced formation of ectopic lymphoid
follicles in Wt but not in CXCR5
−/− mice. Hematoxylin–eosin stainings
of paraffin-embedded gastric mucosal tissue sections of three represen-
tative H. pylori-infected Wt mice (a) and CXCR5
−/− mice (b)5 –
17 months after infection. Eleven out of 13 CXCR5
−/− mice completely
lacked lymphoid aggregates (one representative example, left panel),
and two CXCR5
−/− mice showed loose inflammatory aggregates
(middle and right panel). Scale bars,1 0 0μm
1174 J Mol Med (2010) 88:1169–1180infiltration, increased epithelial proliferation, and gastric
atrophy. In contrast, CXCR5
−/− mice showed a reduced
gastric inflammation, decreased epithelial proliferation, and
subsequently less reactive epithelial pathomorphological
changes. This observation is consistent with our previous
work using a model of chronic antigen-induced rheumatoid
arthritis showing that CXCR5 deficiency leads to a
reduction of acute inflammatory parameters, significantly
reduced numbers of tertiary lymphoid follicles, and reduced
joint destruction [9]. Thus, we have been able to demon-
strate CXCR5-dependent formation of tertiary lymphoid
tissue and their association with local aberrant chronic
immune responses in two independent inflammatory
disease models.
Since B cell homing, the development of PPs and some
peripheral LNs, as well as GC formation, is generally
impaired in these mice [23], reduced inflammation in
CXCR5
−/− mice might also be explained by an impaired
induction of secondary immune responses. However,
comparable bacterial burdens in Wt and CXCR5
−/− mice
suggest that susceptibility to H. pylori infection was not
altered by CXCR5 deficiency and that CXCR5
−/− mice are
still able of mounting an anti-H. pylori immune response.
This conclusion is supported by the capability of both, Wt
and CXCR5
−/− mice, to develop a Th1-like response
towards H. pylori with production of IFN-γ. IFN-γ has
been described as a key cytokine for Th1 cell-mediated
immune responses in the control of Helicobacter infection
[28–30, 37]. It induces phagocytosis by neutrophils and
microbicidal activity and augments the antigen-presenting
activity of macrophages and DCs. Although multiple cell
types can produce IFN-γ, its secretion by CD4
+ Th1 cells
seems to be crucial for bacterial clearance [38]. Consistent
with previous studies [29, 30, 37], we found that lympho-
cytes and splenocytes from H. pylori-infected Wt or
CXCR5
−/− mice produced the Th1-cytokine IFN-γ when
they were restimulated with H. pylori sonicate in vitro.
However, IFN-γ can play a dual role in the pathology of
Helicobacter infection: IFN-γ- and interferon regulatory
factor 1-deficient mice show less gastric inflammation and
Fig. 3 Reduced mucosal prolif-
eration and reactive epithelial
changes in Helicobacter pylori-
infected CXCR5
−/− mice. a
Mucosal proliferation is indicat-
ed by Ki67-staining in red
(indicated by an arrow). A
lower (upper panels) and higher
magnification (lower panels)
of each group is shown; scale
bars, 100 μm. b Reactive
epithelial changes including
epithelial hyperplasia and
epithelial regeneration were
semi-quantitated using a score
of 0–2. The black bar indicates
the mean of Wt (n=12), and the
gray bar the mean of CXCR5
−/−
(n=13) mice. Statistically
significant differences between
Wt and CXCR5
−/− mice are
indicated by asterisks;* P<0.05;
unpaired Student's t test
J Mol Med (2010) 88:1169–1180 1175enhanced colonization with H. pylori, suggesting that while
IFN-γ is known to protect against H. pylori infection by
limiting bacterial growth, upregulation of IFN-γ can
promote chronic gastric inflammation [29, 30, 37]. Here,
we showed that the IFN-γ-mediated Th1 response during
the chronic phase of infection is not significantly altered by
the lack of CXCR5.
More recently, another proinflammatory cytokine, IL-
17A, has been proposed to exert an important role in
anti-Helicobacter mucosal immune responses as well [39].
In several mouse models, it was shown that the host's
ability to kill invading pathogens is partially dependent on
the IL-23/IL-17 axis [39–41]. In our model, a Th17
response was also elicited. Cells cultured from the mLNs
Fig. 4 Lack of segregated ec-
topic follicular tissue formation
in CXCR5
−/− compared to Wt
mice. Paraffin sections with ec-
topic lymphoid follicles of two
representative Wt (a) and sec-
tions with loose lymphoid
aggregates of two CXCR5
−/−
mice (b)5 –17 months after
infection were immunohisto-
chemically stained for B (B220
in red) and T (CD3 in blue)
cells, for macrophages (F4/80 in
red) and B cells (B220 in blue),
and for blood vessel formation
(CD31 in red, indicated by
arrows) and B cells (B220 in
blue). Scale bars, 100 μm
1176 J Mol Med (2010) 88:1169–1180of Wt mice expressed increased IL-17A levels after in
vitro restimulation with H. pylori sonicate in comparison
to uninfected controls. In contrast, cells from the mLNs of
infected CXCR5
−/− mice showed almost no increase in IL-
17A levels. This suggests that CXCR5 deficiency alters
IL-17-producing T cell responses upon H. pylori infec-
tion. The effect of IL-17A on Helicobacter-induced
immune responses remains unclear. Recent work has
shown that deletion of the IL-17 gene inhibited H.
pylori-induced gastritis [42]. In contrast, Ab-mediated
neutralization of IL-17A [43]o rb l o c k a g eo fI L - 1 7 R A
signaling by employing IL-17RA-deficient mice [44]l e d
to an upregulation of chronic mononuclear inflammation
elicited by H. pylori infection. IL-17RA-deficient mice
also exhibited elevated mucosal levels of the B cell
chemoattractant CXCL13. It was suggested that increased
CXCL13 levels cause the accelerated B cell-predominant
chronic inflammation in the IL-17RA-deficient mice [44].
In our study, decreased expression of IL-17A in the
CXCR5
−/− mice was not associated with increased
mononuclear infiltration. Because CXCL13/CXCR5-
mediated effects are blocked in the CXCR5
−/− mice, our
findings are not mutually exclusive to the data of Algood
et al.
A striking difference between Wt and CXCR5
−/− mice
was seen in H. pylori-specific serum IgG and IgA Ab
responses 4 and 7 months after infection. Wt mice
mounted a strong anti-H. pylori IgA and IgG Ab response,
whereas the majority of CXCR5
−/− mice showed only
weak anti-H. pylori IgA and IgG Ab titers. Basal serum
levels for the same subclasses of immunoglobulin were
comparable for non-infected CXCR5
−/− and Wt mice as
described earlier [23, 34]. Additionally, CXCR5
−/− mice
exhibited normal levels of switched Ig isotypes after
immunization with DNP-keyhole limpet hemocyanin
[23]. More recently, the impact of CXCR5 on antiviral B
Fig. 5 Mucosal tertiary lym-
phoid tissues in WT mice ex-
hibit lymph node-like structures.
Paraffin sections with ectopic
lymphoid follicles of represen-
tative Wt mice were immuno-
histochemically stained for the
formation of HEVs (PNAd, pe-
ripheral lymph node addressin,
in red, indicated by arrows; a),
regulatory T cells (Foxp3 in red;
c), lymphocytic proliferation
(Ki67 in red; d), together with
B220 staining (in blue) for B
cells and plasma cells (CD138
in red, indicated by an arrow;
e). Scale bars, 100 μm. Immu-
nofluorescence and immunohis-
tochemical stainings of frozen
sections show CD11c
+ DCs (in
blue) scattered within the T cell
zone (CD3
+ T cells in green; b)
and FDCs (in red) located with-
in the B cell follicle (f). Scale
bar, 100 μm
J Mol Med (2010) 88:1169–1180 1177cell responses was assessed. CXCR5
−/− mice produced
normal levels of neutralizing IgM and IgG Abs in an acute
infection with vesicular stomatitis virus (VSV) and also
developed VSV-specific GCs [45]. However, under con-
ditions of limited antigenic doses, humoral antiviral B cell
responses were significantly reduced in CXCR5
−/− mice
due to impaired Ag-specific expansion of B cells in
secondary lymphoid organs and impaired recruitment of
Ag-specific B and Th cells to GCs [45]. Recently, it has
been demonstrated that H. pylori is predominantly
phagocytosed by DCs in PPs but not in the gastric lamina
propria or gastric epithelium [46, 47]. Subsequently, H.
pylori antigen-specific CD4
+ T cells are primed in PPs and
in mLNs. Since CXCR5
−/− mice have severely reduced
numbers of PPs, one could envisage that less antigen-
loaded DCs are generated which could eventually reach
the mLN for the priming of T cells. Under such circum-
stances, lack of CXCR5 might lead to impaired efficacy of T
cell-dependent B cell responses against Helicobacter-infec-
tion, resulting in a reduced anti-Helicobacter humoral
response. In addition, reduced antigenic priming within the
mLNs might also influence IL-17A and IL-22 production in
mLN-derived cells of infected CXCR5
−/− mice.
In summary, our data indicate that CXCR5 crucially
regulates the formation of organized ectopic lymphoid
follicles during chronic H. pylori-induced gastritis. Lack
of tertiary lymphoid tissue development is additionally
accompanied by reduced chronic gastric inflammation. We
propose that CXCR5 is a promising therapeutic target in
chronic inflammation not only associated with autoimmune
diseases but also during chronic infectious diseases.
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Fig. 7 Decreased serum levels of anti-Helicobacter pylori-specific
IgG and IgA in CXCR5
−/− mice. a Six to seven months after infection,
blood sera from Wt (black bar; n=17) and CXCR5
−/− mice (gray bar;
n=18) were analyzed for the presence of H. pylori-specific IgG (a)
and IgA (b) Abs by ELISA. Non-infected Wt (hatched black bar; n=
5) and CXCR5
−/− mice (hatched gray bar; n=5) served as controls.
Sera were diluted 1:500 for IgA and 1:400 for IgG measurements, and
the absorbance at 450 nm represents the relative anti-H. pylori IgG or
IgA value. Data represent the arithmetic means ± SEM of two
independent experiments. **P<0.01, unpaired Mann–Whitney test
Fig. 6 Helicobacter pylori-specific Th17 cell proliferation was
reduced, but the Th1 responses were unaltered in CXCR5
−/− mice.
Seven months after infection, cell suspensions from mesenteric LNs
and spleens of Wt (black bars; n=6–7) and CXCR5
−/− mice (gray
bars; n=6–7) were restimulated in vitro (1×10
6 cells) with or without
H. pylori sonicate (100 μg/ml) for 72 h. Undiluted supernatants were
analyzed for IFN-γ (a), IL-17A (b), and IL-22 (c) by ELISA. The
mean cytokine release from cells of non-infected Wt mice (n=3) and
CXCR5
−/− mice (n=3) was subtracted from each individual-infected
animal. Bars represent the arithmetic means ± SEM. *P<0.05 and
**P<0.01; unpaired Mann–Whitney test
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